News Center

Home page

Peak Report

News reports

Jianfeng Group 2017-017 (Announcement on Illegal Trading of Stocks by Senior Managers of the Company and Apology)

Release time:

2020-08-05

Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: 2017-017

Bond Abbreviation: 13 Peak 01 Bond Code: 122227

Bond Abbreviation: 13 Peak 02 Bond Code: 122344

Zhejiang Jianfeng Group Co., Ltd.

Announcement

on Illegal Stock Trading and Apology by Senior Managers of the Company The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .

On July 19, 2017 , Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company" and "the company") received a report from Mr. Zhang Fengliang, deputy general manager of the company. There is a situation of illegal trading of company stocks in its securities account. The relevant matters are hereby disclosed as follows:

Basic information of 1.'s stock trading

Mr. Zhang Fengliang was appointed as the senior manager (deputy general manager) of the company on November 12, 2014 . Mr. Zhang Fengliang has been working in other places for a long time, and his stock account is managed by his family members. His family members bought 2,200 shares of the company's stock on July 17, , 2017 , without the knowledge of Mr. Zhang Fengliang , with an average transaction price of 16.61 yuan/share and a transaction amount of 36,542 yuan. On July 18, 2017, 500 shares of the company's stock were sold, with an average transaction price of 17.392 yuan/share, the transaction amount was 8,696 yuan, with a gain of 391.00 yuan. Up to now, Mr. Zhang Fengliang holds 1,700 shares. As the company disclosed the 2017 semi-annual performance forecast on July 18, 2017, the above-mentioned transactions violated the "Rules for the Management of the Company's Shares Held by Directors, Supervisors and Senior Managers of Listed Companies and Their Changes" and "Shareholders of Listed Companies, Directors, Supervisors, and Senior Management Several Provisions on Shareholding Reduction" violated the provisions of Article 47 of the "Securities Law" and constituted short-term trading and sensitive period trading.

Handling of 2. matters

As a senior manager of the company, Mr. Zhang Fengliang neglected to effectively convey and transmit relevant laws and regulations and securities trading rules to his family, resulting in illegal trading of company stocks in his securities account. The board of directors of the company made the following decision on Mr. Zhang Fengliang's illegal behavior:

, the company has made serious criticism and education to Mr. Zhang Fengliang, it is required to seriously study the securities law, the Listing Rules of Shanghai Stock Exchange, the rules on the management of shares held by directors, supervisors and senior managers of listed companies and their changes, and provisions on the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies and other relevant laws, regulations and normative documents, and require them to be strictly implemented.

, Mr. Zhang Fengliang's illegal transaction resulted in income 391.00 yuan. The board of directors of the company collected the illegal income from him in accordance with relevant regulations and imposed a fine of three times (1173 yuan) from the transaction as a minor punishment.

, Mr. Zhang Fengliang himself made a deep reflection on this illegal trading of the company's shares, and promised to withdraw his account and restrain his family's stock trading behavior to avoid the recurrence of such incidents.

, the board of directors requires the remaining 1700 shares of the company not to reduce their holdings during the company's tenure.

. The board of directors of the company notified all directors, supervisors and senior managers of the company of this matter, and criticized Mr. Zhang Fengliang within the company, requiring all directors, supervisors and senior managers of the company to take this as a warning, strengthen the study of relevant laws and regulations, strengthen the management of securities accounts, and strictly regulate the behavior of buying and selling company stocks.

3. Other Supplementary Disclosures

Mr. Zhang Fengliang deeply regrets the occurrence of this illegal transaction, is willing to accept the above handling decision made by the board of directors of the company, and sincerely apologizes to the investors for this illegal transaction.

The company will further strengthen the organization of directors, supervisors, and senior management to the "Securities Law", "Shanghai Stock Exchange Stock Listing Rules",

"The Company's Shares Held by Directors, Supervisors and Senior Management of Listed Companies" and "Regulations on the Reduction of Shares by Shareholders, Directors, Supervisors and Senior Executers' Shares" and other relevant laws, regulations, and regulatory documents study, it also requires all relevant personnel themselves and their relatives to strictly abide by the relevant regulations to prevent the recurrence of such situations.

hereby announces

Zhejiang Jianfeng Group Co., Ltd. Board of Directors

July 20, 2017

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页